PT Phapros Tbk (ISX:PEHA) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


ISX:PEHA PT Phapros Tbk ISX:PEHA
74 GF Score
Price Rp260.00
GF Value Rp385.70
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is PT Phapros Tbk Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

PT Phapros Tbk's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ISX:PEHA vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Phapros Tbk's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Phapros Tbk Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Phapros Tbk's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where PT Phapros Tbk's Margin of Safety % (DCF Earnings Based) falls into.


ISX:PEHA
74GF Score
PT Phapros Tbk ISX:PEHA
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued. The current stock price of Rp260.00 is trading 32.6% below its estimated GF Value™ of Rp385.70. GuruFocus considers PT Phapros Tbk to be Possible Value Trap.

Key valuation signals for ISX:PEHA:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: Rp385.70 vs. price of Rp260.00 (32.6% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Phapros Tbk Business Description

Address Jl. Dr. Ide Anak Agung Gde Agung, Menara Rajawali Lt. 17, Kuningan, Jakarta Selatan, Jakarta, IDN, 12950
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
74GF Score

Get the complete analysis for ISX:PEHA

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp260.00
Price
Rp385.70
GF Value